Aron Starosta, Ph.D. Joins University City Science Center As Vice President, Commercialization and New Ventures
(Original Post) – PHILADELPHIA, PA — (December 2, 2020) – Aron Starosta, Ph.D. has joined the University City Science Center as Vice President, Commercialization and New Ventures.
With close to 30 years in healthcare and venture capital reviewing the technical and commercial investment viability of numerous start-ups, Dr. Starosta will build on the Science Center’s legacy of supporting promising technology and startups through its suite of Commercialization programs.
Over the 25 years, Dr. Starosta has consulted and run over 25 accelerators on behalf of universities, nonprofit research entities, and multiple $1B+ corporations. Among them, the Science Center’s Digital Health Accelerator and most recently, the Launch Lane Accelerator which have collectively supported 27 companies that have gone on to raise over $100M+ in follow-on funding and raise $50M+ in revenue.
“Aron brings a wealth of knowledge and depth of commercialization experience to the Science Center,” says Tiffany Wilson, President & CEO of the University City Science Center. “I’ve had the pleasure of working with him for years including as a selection team member on the Science Center’s Digital Health Accelerator. I’ve been incredibly impressed with his ability to identify and address the unique needs of healthcare startups and codify that support into successful accelerator programs. Further, his commitment to identifying and supporting diverse founders is central to the Science Center’s mission and under his leadership, we’re eager to double down on that support.”
Through faculty appointments at the schools of medicine at New York University and University of Pennsylvania, Aron has seen the drug development process through most of it phases and has been employed as an addiction-domain expert by a number of pharmaceutical companies. In this latter capacity, Aron worked as a researcher and a national speaker on the development and treatment of medications to treat various forms of addiction, including addiction to opiates and alcohol. Aron has also served as an independent information technology consultant, working on process management and technology transfer.
Dr. Starosta completed his bachelor’s degree at McGill University and received advanced degrees in psychology and neuroscience from Temple University.
Through its Commercialization programs, Science Center is a leader in the development of biotechnology across the region. Equipped with deep expertise both in-house and in its network of advisors, the Science Center efficiently identifies, evaluates, accelerates, and finances the most promising life science ideas and businesses. Over the last 10 years, the Science Center has supported over 500 companies, investing over $13M. Those companies have gone on to raise over $900M in follow-on funding and create over 500 jobs.
About the Science Center
Located in the heart of uCity Square, the Science Center is a mission-driven nonprofit that commercializes promising technology, cultivates talent and convenes people to inspire action. For over 50 years, the Science Center has supported startups, research, and economic development across the emerging technology sectors. As a result, Science Center-supported companies account for one out of every 100 jobs in the Greater Philadelphia region and drive $13 billion in economic activity in the region annually. By providing the right help at the right time, the Science Center is turning bright ideas into businesses and nurturing a workforce to support our 21st century economy. For more information, visit www.sciencecenter.org.
Latest posts by Chris Frew (see all)
- Gyroscope Therapeutics, which has operations in King of Prussia, raises $148M - March 31, 2021
- TCR² Therapeutics Acquires Cell Therapy Manufacturing Facility & New VP of Technical Operations, Aaron Vernon - March 29, 2021
- Frederick Based Biotech Law Firm McBee Moore & Vanik IP, LLC Celebrates Five Years - February 18, 2021
- Heather Mudrick Joins Workforce Genetics to Lead Clinical Search Practice - February 12, 2021
- RNA Disease Diagnostics, Inc. Takes Exclusive License to Cutting-Edge Molecular RNA Diagnostic Platform Technology from UMB and UMBC - February 4, 2021